The allotment of the IPO of pharmaceutical company Amanta Healthcare is going to be finalized today, September 4. This IPO received an overwhelming response from investors, and it was subscribed 82.52 times its offer size. The company had set a target of raising ₹ 126 crore through this IPO, in which 1 crore new shares were issued. Its price band was fixed at ₹ 120-126 per share. Let us tell you the step by step process to check the allotment and what is the latest GMP.
Voltamp Transformers Limited said that its promoter Kunjal Patel is planning to sell about 7% equity of the company i.e. 7.88 lakh shares through a block deal. The size of this transaction is about $67 million and the floor price has been fixed at ₹ 7,600 per share. At the same time, the last closing price of the stock is ₹ 7,777.50.
❇️ AmbujaCement reports its Q4 earnings. Other Income at ₹573 cr vs ₹1,352 cr (QoQ)
👉Net Profit Down 55% At ₹956.3 Cr Vs ₹2,115.3 Cr (QoQ)
👉Revenue Up 6% At ₹9,889 Cr Vs ₹9,329 Cr (QoQ)
👉EBITDA Up 9% At ₹1,867 Cr Vs ₹1,712 Cr (QoQ)
👉Margin At 18.9% Vs 18.4% (QoQ)
--Growth Of 13% YoY, At 18.7 Mt, Highest Ever Sales Volume In A Quarter
--Standalone Volumes Up 22% YoY At 11.6 Mt Vs 9.5 Mt
👉Net Profit Down 55% At ₹956.3 Cr Vs ₹2,115.3 Cr (QoQ)
👉Revenue Up 6% At ₹9,889 Cr Vs ₹9,329 Cr (QoQ)
👉EBITDA Up 9% At ₹1,867 Cr Vs ₹1,712 Cr (QoQ)
👉Margin At 18.9% Vs 18.4% (QoQ)
--Growth Of 13% YoY, At 18.7 Mt, Highest Ever Sales Volume In A Quarter
--Standalone Volumes Up 22% YoY At 11.6 Mt Vs 9.5 Mt
Japan's Sumitomo Mitsui is likely to sell its entire 1.65% stake in Kotak Mahindra Bank through a block deal soon . CNBC-Awaaz has given this information today on 9 September, quoting sources. According to sources, Sumitomo will sell 3.28 crore shares of private companies to raise Rs 6,000 crore. Brokerage firms have approached FIIs and mutual funds showing interest in the block deal. Sumitomo wants to use the money received from this sale for the Yes Bank deal.
Suryoday Small Finance Bank shares have announced the grant of 5,30,357 Employee Stock Options (ESOPs) to its eligible employees under the Suryoday ESOP Scheme 2019. The grant was approved by the Nomination and Remuneration Committee (NRC) of the Board on September 10, 2025. Each option has a face value of ₹10 and is granted at a price of ₹181.30 per ESOP.